vertebral fracture

Related by string. vertebral fractures * Vertebral : vertebral compression fractures . vertebral augmentation . vertebral compression fractures VCFs / Fracture . Fractures . FRACTURE : multiple skull fractures . depressed skull fracture * prevalent vertebral fracture . osteoporotic vertebral fractures . morphometric vertebral fractures . non vertebral fractures *

Related by context. All words. (Click for frequent words.) 77 nonvertebral fractures 76 vertebral fractures 74 fragility fracture 72 nonvertebral fracture 72 hip BMD 71 subtrochanteric 70 morphometric vertebral fractures 70 recurrent VTE 70 osteoporotic fracture 70 osteopenic 69 hip fracture 69 osteoporotic 69 advanced adenomas 68 carotid stenosis 68 thromboembolic events 68 fragility fractures 68 definite stent thrombosis 68 advanced adenoma 68 perioperative mortality 68 femoral shaft fractures 68 subclinical hypothyroidism 67 postoperative complication 67 spine fractures 67 pathologic fractures 67 atypical fractures 67 osteoporotic fractures 67 thromboembolism 67 colorectal adenoma 67 venous thrombosis 67 XIENCE V PROMUS Stent 66 nonfatal MI 66 reinfarction 66 symptomatic VTE 66 locoregional recurrence 66 ischemic cardiomyopathy 66 femoral neck BMD 66 postoperative mortality 66 thromboembolic 65 MetS 65 CVD mortality 65 recurrent ischemia 65 femoral neck fracture 65 polyp recurrence 65 arterial thromboembolic events 65 venous thromboembolism 65 revascularizations 65 endometrial carcinoma 65 β blockers 65 endometrial hyperplasia 65 postoperative AF 65 binary restenosis 65 upper gastrointestinal bleeding 65 biochemical recurrence 65 NMIBC 65 perioperative complications 65 femoral shaft fracture 65 macrovascular 64 Erythropoietic therapies may 64 revascularization procedures 64 premenopausal 64 postoperative infection 64 nonoperative treatment 64 acetabular dysplasia 64 confidence interval #.#-#.# 64 ipsilateral stroke 64 strontium ranelate 64 mineral density 64 reoperations 64 microalbuminuria 64 femoral neck 64 thromboembolic complications 64 cardiovascular mortality 64 proximal DVT 64 undergone radical prostatectomy 64 thrombotic events 64 systemic embolism 64 oophorectomy 64 recurrent venous thromboembolism 64 recurrent miscarriage 64 LV dysfunction 64 lumbar spine BMD 64 TEAEs 64 hemorrhagic complications 64 hip fractures 64 post thrombotic syndrome 64 rebleeding 64 liver transplant recipients 64 hsCRP levels 64 coronary stenosis 64 nondiabetic patients 64 spine BMD 64 variceal bleeding 63 Kaplan Meier analysis 63 MACCE 63 non valvular atrial 63 atherogenic dyslipidemia 63 plain radiographs 63 microvascular complications 63 pathologic fracture 63 T2DM 63 deep venous thromboses 63 glycated hemoglobin levels 63 CHD mortality 63 patients undergoing CABG 63 colorectal neoplasia 63 periprocedural 63 left ventricular dysfunction 63 osteoporotic vertebral compression fractures 63 histologically confirmed 63 non vertebral fractures 63 adenoma recurrence 63 periprocedural MI 63 HbA 1c levels 63 mL/min/#.# m 2 63 biochemical relapse 63 serum aminotransferase levels 63 undergoing coronary angiography 63 virological failure 63 serum phosphate 63 nonfasting triglyceride levels 63 contrast induced nephropathy 63 ALT flares 63 macroalbuminuria 63 #.#ng/ml 63 underwent CABG 63 anovulatory infertility 63 elevated troponin 63 hypercalcemia 63 knee OA 63 myocardial infarctions 63 postoperative morbidity 63 contralateral breast cancer 63 colorectal adenomas 62 venous thromboembolic disease 62 meniscectomy 62 virologic failure 62 bisphosphonate therapy 62 % CI #.#-#.# [003] 62 venous thromboembolic events 62 mineral density BMD 62 serum uric acid 62 A1c levels 62 severe hypoglycemia 62 hematuria 62 pCR 62 troponin T 62 CI #.#-#.# [001] 62 thromboses 62 postoperative delirium 62 thyrotropin levels 62 subclinical atherosclerosis 62 intracerebral hemorrhage 62 recurrent UTI 62 symptomatic fibroids 62 recurrent DVT 62 cerebrovascular events 62 urolithiasis 62 renal scarring 62 lipid lowering therapy 62 NATRECOR ® 62 serum PSA 62 venous thromboembolism VTE 62 PSA nadir 62 REYATAZ r arm 62 treated nonoperatively 62 ATACAND 62 PASI scores 62 perimenopausal women 62 BRCA2 mutation carriers 62 cardioembolic stroke 62 recurrent atrial fibrillation 62 ischemic complications 62 beta blocker therapy 62 Complication rates 62 XIENCE V demonstrated 62 bone fracture 62 nonmelanoma skin cancers 62 perioperative morbidity 62 overt hepatic encephalopathy HE 62 tirofiban 62 gout flares 62 atherothrombotic events 62 comorbidities 62 asymptomatic carotid stenosis 62 EBRT 62 spontaneous preterm delivery 62 colectomy 62 Subgroup analyzes 62 oxycodone CR 62 tumor recurrence 62 femoral neck fractures 62 adrenalectomy 62 undergoing bariatric surgery 62 microbleeds 62 coronary calcification 62 thrombotic complications 62 stable angina 62 Stent thrombosis 62 myocardial infarction 62 total thyroidectomy 62 elevated triglyceride levels 62 cerebral infarction 62 nonvertebral 62 eplerenone 62 virologic response 62 umol L 61 hematologic toxicity 61 HGPIN 61 renal impairment 61 intact parathyroid hormone 61 endometrial thickness 61 distant metastases 61 intravesical therapy 61 elevated ALT 61 angiographic outcomes 61 renal dysfunction 61 % CI #.#-#.# [006] 61 cryptogenic stroke 61 paroxysmal AF 61 SLNB 61 CIN3 61 intravenous bisphosphonates 61 neurologic complications 61 hypoglycemic episodes 61 T1DM 61 postoperative atrial fibrillation 61 adenoma 61 univariate analysis 61 N telopeptide 61 precancerous cervical 61 paclitaxel eluting stents 61 recurrent stroke 61 underwent resection 61 ximelagatran 61 PSADT 61 TAXUS Express Stent 61 myocardial infarction MI 61 BMD measurements 61 nulliparous women 61 Protelos 61 chronic periodontitis 61 coronary artery stenosis 61 STRIDE PD 61 dyspareunia 61 COPD exacerbation 61 radiotherapy RT 61 bilateral oophorectomy 61 serum testosterone 61 advanced neoplasia 61 CYPHER Stent 61 intraoperative complications 61 prostate cancer CaP 61 invasive ductal 61 atypical hyperplasia 61 elevated CRP 61 LUTS 61 endometrial cancers 61 angiographic restenosis 61 cervical intraepithelial neoplasia 61 baseline HbA1c 61 haemorrhagic stroke 61 gallstone disease 61 postmenopausal 61 adjunctive placebo 61 keloid scarring 61 risedronate 61 leukemia AML 61 preoperative PSA 61 severe exacerbations 61 acetabular fracture 61 spontaneous preterm birth 61 leiomyomas 61 chorioamnionitis 61 clodronate 61 hypoglycemic events 61 EDSS scores 61 detrusor overactivity 61 mixed hyperlipidemia 61 vertebral compression fractures 61 HbA1C levels 61 thromboprophylaxis 61 hypopituitarism 61 hemodialysis patients 61 % CI #.#-#.# [008] 61 gross hematuria 61 highest tertile 61 nontraumatic 61 PCa 61 glycated hemoglobin HbA1c 61 postintervention 61 HBeAg positive patients 61 retrograde ejaculation 61 androgen deprivation 61 proliferative diabetic retinopathy 61 serum IGF 61 atrophic gastritis 61 premenopausal breast cancer 61 symptomatic intracranial 61 VTE 61 elevated LDL 61 nodal metastases 61 transaminase elevations 61 adnexal mass 61 logistic regression model 61 vaginal hysterectomy 61 ARCOXIA 61 Hip fracture 61 distant metastasis 61 breast carcinoma 61 systolic dysfunction 60 nonischemic 60 carotid artery stenosis 60 deep venous thrombosis 60 thromboembolic disease 60 postmenopausal osteoporotic women 60 femoral fracture 60 bowel resection 60 artery stenosis 60 platelet reactivity 60 vesicoureteral reflux 60 lipid lowering agents 60 invasive breast cancer 60 premenopausal women 60 mammographic density 60 ventricular tachyarrhythmia 60 intracerebral haemorrhage 60 serum urate 60 elevated IOP 60 ruptured aneurysms 60 oral diclofenac 60 multivessel disease 60 symptomatic aortic stenosis 60 NSTE ACS 60 histological subtype 60 achieved ACR# 60 postmenopausal breast cancer 60 tapentadol ER 60 HbA1c levels 60 calcaneal fractures 60 androgen suppression therapy 60 multivariable adjusted 60 lipid abnormalities 60 unstable angina pectoris 60 atypia 60 radical nephrectomy 60 radiographically 60 hemoglobin A1c levels 60 venous blood clots 60 zoledronic acid 60 malunion 60 cardiovascular hospitalization 60 myocardial infarction stroke 60 cystectomy 60 ertapenem 60 dyslipidaemia 60 glomerular filtration 60 extrapyramidal symptoms 60 femur fractures 60 aminotransferase levels 60 LVEF 60 preintervention 60 atrioventricular block 60 knee osteoarthritis 60 univariate analyzes 60 confidence intervals CIs 60 primary hypercholesterolemia 60 gestational diabetes mellitus 60 timepoint 60 Operative mortality 60 KRAS mutations occur 60 Venous thromboembolism 60 lobular cancer 60 carotid IMT 60 multivariate Cox 60 lumbar disk herniation 60 left ventricular hypertrophy 60 Thal Dex 60 tibolone 60 endometriosis ovarian cysts 60 lumbar spine bone 60 retrospective cohort 60 DEXA scan 60 coronary revascularization 60 Events MACE 60 lopinavir r arm 60 malignant lesions 60 prospectively defined 60 comorbid conditions 60 lowest tertile 60 posttraumatic arthritis 60 undergoing radical prostatectomy 60 HBeAg 60 NHANES III 60 postoperative hemorrhage 60 osteosarcomas 60 CTEPH 60 intracranial hemorrhage ICH 60 distal colon cancer 60 CDI recurrence 60 androgen suppression 60 lumbar disc herniation 60 precancerous cervical lesions 60 CLA supplementation 60 evaluable subjects 60 CIN2 + 60 hepatic cirrhosis 60 GnRH agonist 60 enzyme elevations 60 hypercalciuria 60 colorectal polyp 60 transferrin saturation 60 hyperphenylalaninemia HPA due 60 invasive aspergillosis 60 thrombocytopenic 60 subclinical hyperthyroidism 60 rFVIIa 60 nonoperative 60 FOLFOX4 60 malignant polyps 60 postoperative infections 60 distal radius fracture 60 ADHF 60 hydroxyvitamin D levels 60 chronic GVHD 60 incomplete revascularization 60 repeat revascularization 60 onset diabetes mellitus 60 prognostic variables 60 onset atrial fibrillation 60 clinically localized prostate 60 TNF antagonist 60 5-FU/LV 60 Taxus Stent 60 prostate cancer PCa 60 testicular tumors 60 ejection fractions 60 hypertension diabetes mellitus 60 parous women 60 elagolix 60 hyperbilirubinemia 60 specific antigen PSA 60 TURP 60 prevalent vertebral fracture 60 hemoglobin A1c HbA1c 60 pneumonectomy 60 GnRH agonists 60 grade cervical intraepithelial 60 pretest probability 60 highest quintile 60 neurodevelopmental impairment 60 normotensive 60 lymph node involvement 60 CR nPR 60 secondary hyperparathyroidism 60 aminotransferases 60 elevated LDL cholesterol 60 IV bisphosphonates 60 prior chemotherapy regimens 60 bone metastases 60 tamsulosin 60 adjuvant radiotherapy 60 HBeAg negative 60 MMSE scores 60 preserved ejection fraction 60 epithelial ovarian cancer 60 parathyroidectomy 59 external genital lesions 59 pre menopausal 59 OAB symptoms 59 colorectal neoplasms 59 EXJADE 59 subgroup analyzes 59 Ishak fibrosis score 59 endophthalmitis 59 prolonged QT interval 59 metachronous 59 hypogonadal men 59 % CI #.#-#.# [007] 59 Prehypertension 59 distal radius 59 teriparatide 59 distal radial fractures 59 arthrodesis 59 BRCA mutation carriers 59 moderate renal impairment 59 NYHA class 59 DMARD 59 transurethral resection 59 tertile 59 carotid endarterectomy CEA 59 histologic subtype 59 mg/m2 dose 59 CI #.#-#.# [002] 59 serum estradiol 59 magnesium intake 59 postoperative complications 59 dysglycemia 59 % Confidence Interval 59 lipid lowering drugs 59 psychiatric comorbidities 59 Adjuvant chemotherapy 59 systolic hypertension 59 DES implantation 59 postoperative chemotherapy 59 GERD symptoms 59 HBeAg seroconversion 59 leucopenia 59 serum calcium levels 59 elevated hsCRP 59 atheroma volume 59 intima media thickness 59 MADRS score 59 varicoceles 59 pelvic lymphadenectomy 59 laboratory abnormalities 59 cirrhotic patients 59 HeFH 59 locoregional 59 valvulopathy 59 juvenile idiopathic arthritis 59 axillary lymph nodes 59 antithrombotic therapy 59 receiving VICTRELIS 59 elevated bilirubin 59 invasive candidiasis 59 lateral radiograph 59 ABC/3TC 59 micafungin 59 cerebral vasospasm 59 Osteopenia 59 postmenopausal osteoporosis 59 autonomic dysfunction 59 CC genotype 59 tibiofemoral 59 estrogen deficiency 59 nonrandomized 59 RYGB 59 octreotide LAR 59 liver histology 59 mitral regurgitation 59 flutamide 59 pericardial effusion 59 hypercholesterolaemia 59 cerebrovascular accident 59 urinary N telopeptide 59 varicocele 59 events MACE 59 annualized relapse 59 oncologic outcomes 59 HbA 1c 59 chemoradiotherapy 59 lobular breast cancer 59 spinal fractures 59 PLX STROKE targeting 59 elective PCI 59 hypoglycaemic episodes 59 osteoporotic vertebral fractures 59 venous thromboembolisms 59 curative resection 59 benign breast 59 intraobserver 59 carotid intima media 59 bosentan 59 serum urate levels 59 #mg BID [001] 59 total hip arthroplasty 59 metformin monotherapy 59 neutrophil counts 59 nonfatal stroke 59 hallux valgus 59 hemodynamically significant 59 baseline LDH 59 rosuvastatin #mg 59 recurrent myocardial infarction 59 adjunctive ABILIFY 59 nadroparin 59 severe aortic stenosis 59 BRCA1 mutation carriers 59 DVT PE 59 operable breast cancer 59 fluvastatin 59 histologically proven 59 relapsed MM 59 glycosylated hemoglobin HbA1c 59 tumor histology 59 axillary node dissection 59 Hazard Ratio 59 chronic prostatitis 59 dietary calcium intake 59 ALND 59 anastomotic leak 59 severe mitral regurgitation 59 HNSCC 59 severe hypoglycemic 59 polycystic ovary syndrome PCOS 59 febrile neutropenia 59 grade glioma 59 radical prostatectomy RP 59 breast cancer recurrence 59 density BMD 59 bacterial prostatitis 59 BRCA2 mutations 59 adenomatous polyps 59 vasomotor symptoms 59 VUR 59 ibandronate 59 amenorrhea 59 nonmetastatic prostate cancer 59 5-fluorouracil/leucovorin 59 nocturnal hypoglycaemia 59 obstructive coronary artery 59 ASCUS 59 severe hypoglycaemia 59 HSCT 59 corticosteroid dose 59 reflux symptoms 59 Postoperatively 59 serum calcium 59 P = .# 59 androgen deficiency 59 undergoing coronary artery 59 alendronate 59 obstructive CAD 59 haematologic 59 extracapsular extension 59 lymphadenectomy 59 abnormal mammograms 59 NNRTI resistance 59 decompensated cirrhosis 59 microscopic hematuria 59 HIV HCV coinfected 59 depressive symptomatology 59 mm Stent 59 cilostazol 59 myocardial ischemia 59 confidence interval CI 59 radiographic outcomes 59 Ebstein anomaly 59 sirolimus eluting stents 59 aneurysmal subarachnoid hemorrhage 59 CMV infection 59 cryptorchidism 59 interferon ribavirin 59 SHBG levels 59 LAGB 59 alanine aminotransferase 59 amenorrhoea 59 bezafibrate 59 percutaneous vertebroplasty 59 XGEVA 59 univariate 59 MADIT CRT trial 59 anal incontinence 59 trochanteric 59 NIHSS 59 adenoidectomy 59 renal toxicity 59 euthyroid 59 serum selenium 59 urothelial carcinoma 59 bone metastasis 59 CLBP 58 thyroid dysfunction 58 renal insufficiency 58 antihypertensive therapy 58 everolimus eluting stents 58 aromatase inhibitor therapy 58 Thrombolysis 58 serum creatinine levels 58 calcium supplementation 58 CIN2 58 cardiovascular hospitalizations 58 VTE prophylaxis 58 radical retropubic prostatectomy 58 hyperoxaluria 58 serum triglycerides 58 Febrile neutropenia 58 tibial shaft 58 laparoscopically assisted 58 BENICAR HCT 58 parkinsonian symptoms 58 PRADAXA #mg 58 nephrotoxicity 58 prostate carcinoma 58 aminotransferase ALT 58 hypocalcemia 58 inhospital 58 APTIVUS r 58 PAOD 58 statin therapy 58 nephropathy 58 diabetes mellitus 58 ALT elevation 58 wound dehiscence 58 mg BID dose 58 pamidronate 58 NSTEMI 58 radioiodine therapy 58 nonpregnant women 58 carotid artery stenting CAS 58 infarctions 58 osteopenia 58 HoLEP 58 contralateral breast 58 imatinib therapy 58 CCyR 58 Subgroup analysis 58 cartilage lesions 58 multivariable analysis 58 alendronate Fosamax 58 #mmHg [001] 58 Toxicities 58 Postoperative complications 58 glucocorticoid induced osteoporosis 58 TAXUS p value 58 CK MB 58 salpingo oophorectomy 58 asymptomatic PAD 58 HOMA IR 58 incontinence episodes 58 ruboxistaurin 58 atherothrombotic disease 58 nephrolithiasis 58 angiographically 58 hypercholesterolemic patients 58 multivariate adjustment 58 death reinfarction 58 RLS symptoms 58 anastrozole 58 albuminuria 58 salivary flow 58 hypophosphatemia 58 liver resection 58 knee osteoarthritis OA 58 atypical ductal hyperplasia 58 serum prostate 58 neurocognitive deficits 58 osteoporotic bone 58 nodal metastasis 58 atherosclerotic progression 58 hemiarthroplasty 58 graft occlusion 58 NATRECOR R 58 Hazard Ratio HR 58 SRBD 58 URTI 58 heparin induced thrombocytopenia 58 placebo dexamethasone 58 ICD implantation 58 reintervention 58 ARB telmisartan 58 reoperation 58 NYHA Class II 58 posttreatment 58 postmenopausal women 58 elevated triglycerides 58 Primary endpoints 58 ‰ ¥ 58 metastatic lung cancer 58 serum lipid levels 58 preterm delivery 58 hsCRP 58 arthropathy 58 severe neutropenia 58 spinal cord compression 58 â ‰ ¥ 58 Serious adverse reactions 58 aldosterone antagonist 58 TMP SMX 58 parathyroid carcinoma 58 composite endpoint 58 knee arthroplasty 58 CIMZIA ™ 58 CrCl 58 benazepril 58 abnormal uterine bleeding 58 ACEI ARB 58 preoperatively 58 Crohn Disease Activity 58 ductal carcinomas 58 Radical prostatectomy 58 CIMZIA TM certolizumab pegol 58 dose ionizing radiation 58 DEXA scans 58 abdominal adiposity 58 refractory ischemia 58 ticlopidine 58 developmental dysplasia 58 candesartan 58 periprosthetic fracture 58 artery calcification 58 TAXUS Stent 58 GI bleeding 58 arteriography 58 ribavirin therapy 58 diverticular bleeding 58 perioperatively 58 preoperative chemotherapy 58 latent celiac disease 58 HBV infections 58 invasive fungal infection 58 prior nephrectomy 58 treatment emergent AEs 58 dose statin therapy 58 pancreatic adenocarcinoma 58 peripheral sensory neuropathy 58 chemoradiation 58 hypertensives 58 oral anticoagulant therapy 58 prognostic factors 58 nonmelanoma skin cancer 58 fallopian tube cancers 58 basal cell carcinoma BCC 58 ECG abnormalities 58 ELBW infants 58 antihypertensive medications 58 chlorambucil 58 NIHSS score 58 BRCA1 mutations 58 proliferative retinopathy 58 posterior vitreous detachment 58 noncardiac 58 multivariate analyzes 58 PREZISTA r arm 58 QTc 58 % CI #.#-#.# [004] 58 Procoralan 58 left ventricular systolic 58 embolic stroke 58 VADT 58 sustained virological response 58 Index CDAI 58 pulmonary exacerbation 58 renal artery stenosis 58 pericardial effusions 58 severe psoriasis 58 response pCR 58 lower extremity amputation 58 colorectal polyps 58 prostate TURP 58 timepoints 58 Non inferiority 58 FluCAM arm 58 sirolimus eluting stent 58 mCRC patients 58 cTnT 58 gastrectomy 58 BRCA mutations 58 Hashimoto thyroiditis 58 aseptic loosening 58 postop 58 lymphocytosis 58 varus deformity 58 osteolysis 58 SREs 58 sustained virologic response 58 aromatase inhibitors AIs 58 ulnar styloid 58 Baseline characteristics 58 MIs 58 gestational diabetes mellitus GDM 58 retinal vein occlusion 58 cTnT levels 58 disc herniations 58 gestational hypertension 58 NSAID induced 58 PRADAXA 58 Infusion Reactions Severe 58 cytogenetic response 58 creatinine ratio 58 interobserver reliability 58 VaD 58 sonographic findings 58 cerebral microbleeds 58 hepatotoxicity 58 urinary oxalate 58 reflux esophagitis 58 salmeterol HFA MDI 58 cytoreductive surgery 58 undetectable HBV DNA 58 nonunions 58 recanalization 58 denervation 58 ECOG PS 58 oral bisphosphonate 58 mycophenolate mofetil 58 LNG IUS 58 RBP4 levels 58 Coronary artery bypass grafting 58 revascularization procedure 58 aspartate aminotransferase AST 58 triglyceride concentrations 58 HER2 expression 58 hyperkalemia 58 antiarrhythmic drug 58 oral FTY# 58 VTEs 58 postmenopausal hormones 58 adenotonsillectomy 58 antidiabetic medication 58 adjuvant radiation 58 QTc prolongation 58 elevated LDH 58 tamoxifen therapy 58 neutropenia dehydration dyspnea 58 nonadherence 58 fasting insulin 58 Coronary Artery Bypass Graft 58 T2 lesions 58 asthma exacerbation 58 fasting plasma glucose 58 neoadjuvant 58 carotid plaque 58 inflammatory lesions 58 NAFLD 58 diameter stenosis 58 ischemia driven 58 Heavy menstrual bleeding 58 fasting triglyceride levels 58 mcg QD 58 Calcium intake 58 F FDG PET 58 serum PTH 58 Arch Intern Med 58 diskectomy 58 leukocyte count 58 sirolimus stent 58 chlamydial infection 58 ventricular dysfunction 58 bacteriuria 58 D dimer 58 MitraClip device 58 symptomatic paroxysmal AF 58 discontinuations due 58 polyarticular 58 patients evaluable 58 coronary blockages 58 lipid lowering medications 57 renal biopsy 57 malignant neoplasm 57 osteoporotic hip 57 serum vitamin D 57 hormone receptor negative 57 noncardiovascular 57 unstable angina UA 57 nocturnal hypoglycemia 57 ovarian malignancy 57 APPRAISE 57 pulmonary dysfunction 57 hyperintense lesions 57 renal cell carcinomas 57 syncopal 57 OPCAB 57 CI -#.# 57 glycosylated hemoglobin levels 57 nondiabetic 57 recurrent preterm birth 57 adenomas 57 undetectable PSA 57 candesartan cilexetil 57 acute cholecystitis 57 conjunctival hyperemia 57 LVNC 57 hindfoot 57 femoral fractures 57 malignant neoplasms 57 macrovascular disease 57 poor metabolizers 57 osteoporosis osteopenia 57 serum ALT 57 chondral 57 loop diuretic 57 nonfatal myocardial infarction 57 hypogonadal 57 abdominal hysterectomy 57 arthroplasty 57 idiopathic scoliosis 57 creatinine clearance 57 proximal femur 57 Kaplan Meier estimates 57 logistic regression analysis 57 ductal cancer 57 spondylolisthesis 57 elevated depressive symptoms 57 coronary artery calcification 57 DMARD therapy 57 CMV disease 57 recurrent wheezing 57 ductal breast cancer 57 Patency 57 oral antidiabetic medication 57 symptomatic intracranial hemorrhage 57 prednisone prednisolone 57 proteinuria 57 hypercholesterolemia 57 bowel polyps 57 AVODART 57 diabetes mellitus DM 57 MGUS

Back to home page